TP-0413 is a novel small molecule inhibitor of the BMP pathway that has significant potential to be developed to treat anemia of cancer. Anemia of cancer is cytokine driven and results in the up-regul ...SBIR Phase I 2012 Department of Health and Human Services
TOLERO PHARMACEUTICALS, INC.
| 2975 W. Executive Parkway
Lehi, UT, 84043
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||20|